👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Texas sues doctor for prescribing testosterone to transgender minors

Published 10/17/2024, 03:46 PM
Updated 10/17/2024, 03:50 PM
© Reuters. FILE PHOTO: Syringes are seen in front of a displayed U.S. flag in this illustration taken November 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

By Brendan Pierson

(Reuters) - Texas on Thursday filed what appears to be the first lawsuit against a doctor for allegedly violating the state's ban on providing gender-affirming care, such as puberty blockers and hormones, to transgender minors.

In a complaint filed in the District Court of Collin County, Texas, Texas Attorney General Ken Paxton claimed May Lau, a pediatrician at University of Texas Southwestern Medical Center in Dallas, prescribed testosterone to at least 21 minor patients seeking to transition from female to male. Paxton in the complaint called Lau "a scofflaw who is putting the health and safety of minors at risk."

Lau and UT Southwestern did not immediately respond to requests for comment.

Texas Governor Greg Abbott signed the gender-affirming care law in June 2023. The law states that the medical license of any doctor providing drugs or surgery for the purpose of gender transition to minors must be revoked.

Lau wrote almost all of the prescriptions shortly before the law took effect in September 2023 so that her patients could fill them later, according to the complaint, but Paxton said that counted as providing banned care after the law took effect. He also said that Lau wrote two illegal testosterone prescriptions while the law was in effect.

Paxton further claimed that Lau falsified records to conceal the fact that her patients were transgender, violating Texas's business code.

The lawsuit seeks money damages and a court order preventing Lau from violating the law in the future.

The Texas Supreme Court in June upheld the state's ban on gender-affirming care for minors, rejecting arguments by families with transgender children and doctors that the law was discriminatory and deprived parents of their rights under the state constitution to make decisions concerning their children's care.

© Reuters. FILE PHOTO: Syringes are seen in front of a displayed U.S. flag in this illustration taken November 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Twenty-five Republican-led states have enacted laws or policies that ban or restrict gender-affirming care for minors, according to the Movement Advancement Project, an LGBTQ think tank, and many of those laws have been challenged in court.

The U.S. Supreme Court has agreed to consider a challenge to Tennessee's ban, which could decide whether other states' bans will survive as well.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.